The innovative design of our research approach, integrating MD simulations, virtual screening, and detailed binding stability analyses, provides a valuable framework for identifying and characterizing potential anti-tumor drugs targeting CCND1-CDK4 interactions. Here, CDK4 is linked to neoplasm.